{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T23:21:30Z","timestamp":1790724090827,"version":"4.1.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,9,24]],"date-time":"2021-09-24T00:00:00Z","timestamp":1632441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,9,24]],"date-time":"2021-09-24T00:00:00Z","timestamp":1632441600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1007\/s11239-021-02573-6","type":"journal-article","created":{"date-parts":[[2021,9,24]],"date-time":"2021-09-24T20:09:14Z","timestamp":1632514154000},"page":"601-606","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Adverse events in patients taking apixaban or rivaroxaban who have undergone bariatric surgery: a retrospective case series"],"prefix":"10.1007","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9119-5031","authenticated-orcid":false,"given":"Deborah","family":"DeCamillo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Haymart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey D.","family":"Barnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,24]]},"reference":[{"issue":"11","key":"2573_CR1","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1111\/jth.13139","volume":"13","author":"C Chai-Adisaksopha","year":"2015","unstructured":"Chai-Adisaksopha C, Hillis C, Isayama T, Lim W, Iorio A, Crowther M (2015) Mortality outcomes in patients receiving direct oral anticoagulants: a systematic review and meta-analysis of randomized controlled trials. J Thromb Haemost 13(11):2012\u20132020. https:\/\/doi.org\/10.1111\/jth.13139","journal-title":"J Thromb Haemost"},{"issue":"3","key":"2573_CR2","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s11239-016-1465-x","volume":"43","author":"HA Hakeam","year":"2017","unstructured":"Hakeam HA, Al-Sanea N (2017) Effect of major gastrointestinal tract surgery on the absorption and efficacy of direct acting oral anticoagulants (DOACs). J Thromb Thrombolysis 43(3):343\u2013351. https:\/\/doi.org\/10.1007\/s11239-016-1465-x","journal-title":"J Thromb Thrombolysis"},{"key":"2573_CR3","unstructured":"American Society for Metabolic and Bariatric Surgery website (2020) https:\/\/asmbs.org\/resources\/estimate-of-bariatric-surgery-numbers"},{"issue":"5","key":"2573_CR4","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.amjmed.2016.12.033","volume":"130","author":"KA Martin","year":"2017","unstructured":"Martin KA, Lee CR, Farrell TM, Moll S (2017) Oral anticoagulant use after bariatric surgery: a literature review and clinical guidance. Am J Med 130(5):517\u2013524. https:\/\/doi.org\/10.1016\/j.amjmed.2016.12.033","journal-title":"Am J Med"},{"issue":"4","key":"2573_CR5","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s11239-013-0891-2","volume":"36","author":"A Mahlmann","year":"2013","unstructured":"Mahlmann A, Gehrisch S, Beyer-Westendorf J (2013) Pharmacokinetics of rivaroxaban after bariatric surgery: a case report. J Thromb Thrombolysis 36(4):533\u20135. https:\/\/doi.org\/10.1007\/s11239-013-0891-2","journal-title":"J Thromb Thrombolysis"},{"issue":"12","key":"2573_CR6","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1016\/j.soard.2018.08.025","volume":"14","author":"D Kr\u00f6ll","year":"2018","unstructured":"Kr\u00f6ll D, Nett PC, Borb\u00e9ly YM, Sch\u00e4delin S, Bertaggia Calderara D, Alberio L, Stirnimann G (2018) The effect of bariatric surgery on the direct oral anticoagulant rivaroxaban: the extension study. Surg Obes Relat Dis 14(12):1890\u20131896. https:\/\/doi.org\/10.1016\/j.soard.2018.08.025","journal-title":"Surg Obes Relat Dis"},{"issue":"9","key":"2573_CR7","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1016\/j.amjmed.2017.05.011","volume":"130","author":"KT Moore","year":"2017","unstructured":"Moore KT, Kr\u00f6ll D (2017) Influences of obesity and bariatric surgery on the clinical and pharmacologic profile of rivaroxaban. Am J Med 130(9):1024\u20131032. https:\/\/doi.org\/10.1016\/j.amjmed.2017.05.011","journal-title":"Am J Med"},{"issue":"7","key":"2573_CR8","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1111\/bcp.13243","volume":"83","author":"D Kr\u00f6ll","year":"2017","unstructured":"Kr\u00f6ll D, Stirnimann G, Vogt A, Lai DLL, Borb\u00e9ly YM, Altmeier J, Sch\u00e4delin S, Candinas D, Alberio L, Nett PC (2017) Pharmacokinetics and pharmacodynamics of single doses of rivaroxaban in obese patients prior to and after bariatric surgery. BrJ Clin Pharmacol 83(7):1466\u20131475. https:\/\/doi.org\/10.1111\/bcp.13243","journal-title":"BrJ Clin Pharmacol"},{"key":"2573_CR9","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.thromres.2017.11.006","volume":"163","author":"A Rottenstreich","year":"2018","unstructured":"Rottenstreich A, Barkai A, Arad A, Raccah BH, Kalish Y (2018) The effect of bariatric surgery on direct-acting oral anticoagulant drug levels. Thromb Res 163:190\u2013195. https:\/\/doi.org\/10.1016\/j.thromres.2017.11.006","journal-title":"Thromb Res"},{"issue":"1","key":"2573_CR10","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/fcp.12587","volume":"35","author":"C Leven","year":"2021","unstructured":"Leven C, Hoffmann C, Roche C, Couturaud F, Thereaux J, Lacut K (2021) Impact of bariatric surgery on oral anticoagulants pharmacology, and consequences for clinical practice: a narrative review. Fundam Clin Pharmacol 35(1):53\u201361. https:\/\/doi.org\/10.1111\/fcp.12587","journal-title":"Fundam Clin Pharmacol"},{"key":"2573_CR11","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.jvi.2015.05.003","volume":"55","author":"DA Hanauer","year":"2015","unstructured":"Hanauer DA, Mei Q, Law J, Khanna R, Zheng K (2015) Supporting information retrieval from electronic health records: a report of University of Michigan\u2019s nine-year experience in developing and using the electronic medical record search engine (EMERSE). J Biomed Inform 55:290\u2013300. https:\/\/doi.org\/10.1016\/j.jvi.2015.05.003","journal-title":"J Biomed Inform"},{"key":"2573_CR12","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","volume":"3","author":"S Schulman","year":"2005","unstructured":"Schulman S, Kearon C (2005) Subcommittee on control of anticoagulation of the scientific and standardization committee international society on thrombosis and haemostasis. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non\u2010surgical patients. J Thromb Haemost 3:692\u2013694. https:\/\/doi.org\/10.1111\/j.1538-7836.2005.01204.x","journal-title":"J Thromb Haemost"},{"issue":"11","key":"2573_CR13","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1111\/jth.13140","volume":"13","author":"S Kaatz","year":"2015","unstructured":"Kaatz S, Ahmad D, Spyropoulos AC, Schulman S, Subcommittee on Control of Anticoagulation (2015) Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH. J Thromb Haemost 13(11):2119\u20132126. https:\/\/doi.org\/10.1111\/jth.13140","journal-title":"J Thromb Haemost"},{"issue":"11","key":"2573_CR14","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1056\/NEJMoa1107039","volume":"365","author":"CB Granger","year":"2011","unstructured":"Granger CB, Alexander JH, McMurray JJ, Lopes RD, Hylek EM, Hanna M, Al-Khalidi HR, Ansell J, Atar D, Avezum A, Bahit MC, Diaz R, Easton JD, Ezekowitz JA, Flaker G, Garcia D, Geraldes M, Gersh BJ, Golitsyn S, Goto S, Hermosillo AG, Hohnloser SH, Horowitz J, Mohan P, Jansky P, Lewis BS, Lopez-Sendon JL, Pais P, Parkhomenko A, Verheugt FW, Zhu J, Wallentin L, ARISTOTLE Committees Investigators (2011) Apixaban versus warfain in patients with atrial fibrillation. N Engl J Med 365(11):981\u2013992. https:\/\/doi.org\/10.1056\/NEJMoa1107039","journal-title":"N Engl J Med"},{"issue":"9","key":"2573_CR15","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1056\/NEJMoa1207541","volume":"369","author":"G Agnelli","year":"2013","unstructured":"Agnelli G, Buller HR, Cohen A, Curto M, Gallus AS, Johnson M, Masiukiewicz U, Pak R, Thompson J, Raskob GE, Weitz JI, AMPLIFY Investigators (2013) Oral apixaban for the treatment of acute venous thromboembolism. N Engl J Med 369(9):799\u2013808. https:\/\/doi.org\/10.1056\/NEJMoa1207541","journal-title":"N Engl J Med"},{"issue":"8","key":"2573_CR16","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1056\/NEJMoa1207541","volume":"368","author":"G Agnelli","year":"2013","unstructured":"Agnelli G, Buller HR, Cohen A, Curto M, Gallus AS, Johnson M, Porcari A, Raskob GE, Weitz JI, for the AMPLIFY-EXT Investigators (2013) Apixaban for the extended treatment of acute venous thromboembolism. N Engl J Med 368(8):699\u2013708. https:\/\/doi.org\/10.1056\/NEJMoa1207541","journal-title":"N Engl J Med"},{"issue":"24","key":"2573_CR17","doi-asserted-by":"publisher","first-page":"3042","DOI":"10.1016\/j.jacc.2017.09.1085","volume":"70","author":"GF Tomaselli","year":"2017","unstructured":"Tomaselli GF, Mahaffey KW, Cuker A, Dobesh PP, Doherty JU, Eikelboom JW, Florido R, Hucker W, Mehran R, Mess\u00e9 SR, Pollack CV Jr, Rodriguez F, Sarode R, Siegal D, Wiggins BS (2017) 2017 ACC expert consensus decision pathway on management of bleeding in patients on oral anticoagulants: a report of the American college of cardiology task force on expert consensus decision pathways. J Am Coll Cardiol 70(24):3042\u20133067. https:\/\/doi.org\/10.1016\/j.jacc.2017.09.1085","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"2573_CR18","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.chest.2016.08.1462","volume":"151","author":"B Samuelson","year":"2017","unstructured":"Samuelson B, Cuker A, Siegal D, Crowther M, Garcia D (2017) Laboratory assessment of the anticoagulant activity of direct oral anticoagulants: a systematic review. Chest 151(1):127\u2013138. https:\/\/doi.org\/10.1016\/j.chest.2016.08.1462","journal-title":"Chest"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-021-02573-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11239-021-02573-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-021-02573-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,8]],"date-time":"2022-04-08T08:12:49Z","timestamp":1649405569000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11239-021-02573-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,24]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["2573"],"URL":"https:\/\/doi.org\/10.1007\/s11239-021-02573-6","relation":{},"ISSN":["0929-5305","1573-742X"],"issn-type":[{"value":"0929-5305","type":"print"},{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,24]]},"assertion":[{"value":"12 September 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Deborah DeCamillo declares that she has no conflict of interest. Brian Haymart declares that he has no conflict of interest. Geoffrey Barnes declares that he has received research grants from Blue Cross Blue Shield of Michigan, Agency for Healthcare Research and Quality (AHRQ), and National Health Lung and Blood Institute (NHLBI) and has received personal fees from Jansen, Pfizer\/Bristol Myers Squibb, Acelis Connected Health, and AMAG Pharmaceuticals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The University\u2019s Institutional Review Board (IRB) determined that the study was Exempt from ongoing review due to the retrospective nature of the study and all the procedures being performed were part of the routine care.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable since the University\u2019s IRB gave an Exemption due to the retrospective nature of data collection.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable since the University\u2019s IRB gave an Exemption due to the retrospective nature of data collection.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}